Joshua Schiff, MD

Assistant Professor of Clinical Radiation Oncology

Image of Joshua Schiff, MD
Is this your profile? Click to edit

Overview

Dr. Joshua P. Schiff is an Assistant Professor of Clinical Radiation Oncology at the Keck School of Medicine. He joined the faculty in the fall of 2024. His clinical practice is primarily at the Pasadena Medical Office Building and the Norris Comprehensive Cancer Center. He grew up in Los Angeles in the San Fernando Valley, and graduated from the University of California, Santa Barbara with a bachelor’s degree in Biopsychology. He earned his medical doctorate degree at the Tulane University School of Medicine, where he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed his residency at the Washington University School of Medicine in St. Louis, where he was chief resident. Dr. Schiff specializes in the treatment of a variety of cancer types using advanced radiotherapy delivery methods. His primary clinical focuses include gastrointestinal, thoracic, and breast cancers as well as benign conditions such as osteoarthritis. He has extensive experience with modern treatment techniques including intensity-modulated radiation therapy, volumetric-modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and motion management techniques. He has obtained funding for and opened multiple clinical trials with a focus on the implementation of new technology to improve treatment outcomes for patients, having previously focused on online adaptive radiotherapy, and now focusing on biology-guided radiotherapy. His work has resulted in numerous publications, presentations at national meetings, and awards, including the Roentgen Resident/Fellow Research award from the Radiological Society of North America.

Awards

  • Keck Medicine of USC: ESTRO Annual Conference Top Scoring Abstract, 2025
  • Keck Medicine of USC: Certificate of Academic Achievement, Department of Radiology, 2024
  • Washington University School of Medicine: Roentgen Resident Research Award, 2024
  • Tulane University School of Medicine: Alpha Omega Alpha, 2019

Education and Training

  • Washington University School of Medicine in St. Louis, St. Louis, MO — 06/2024 — Residency – Radiation Oncology
  • Cedars Sinai Medical Center, Los Angeles, CA — 06/2020 — Internship – Internal Medicine
  • Tulane University School of Medicine, New Orleans, LA — MD — 05/2019
  • University of California, Santa Barbara, Santa Barbara, CA — BS — 06/2014

Publications

  • Retrospective analysis of adaptation frequencies and factors in offline in offline adaptive proton therapy. J Appl Clin Med Phys. 2026 May; 27(5):e70604.. View in PubMed
  • Phase I De-escalated RT in Endometrial Cancer. Int J Radiat Oncol Biol Phys. 2026 Jul 15; 125(4):1101-1110.. View in PubMed
  • Direct-to-Unit Stereotactic Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy for Spine Metastasis. Int J Radiat Oncol Biol Phys. 2026 Apr 01; 124(5):1233-1238.. View in PubMed
  • Adaptive radiotherapy for gastrointestinal malignancies. Radiat Oncol. 2025 Nov 20; 20(1):173.. View in PubMed
  • Palliative expeditiously adaptive quad shot radiotherapy for head and neck cancers (PEAQ-RT). Clin Transl Radiat Oncol. 2025 Sep; 54:101012.. View in PubMed
  • Feasibility of Stereotactic Body Radiation Therapy for Pancreatic Tumors Abutting Organs at Risk Using Magnetic Resonance Guided Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2025 07 01; 122(3):668-677.. View in PubMed
  • Stereotactic Body Radiation Therapy for Palliative Reirradiation of Acrometastasis in the Hand From Breast Cancer. Adv Radiat Oncol. 2024 Dec; 9(12):101630.. View in PubMed
  • Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma. Radiother Oncol. 2024 11; 200:110473.. View in PubMed
  • Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy. Cureus. 2024 Aug; 16(8):e66218.. View in PubMed
  • Feasibility of simulation free abdominal stereotactic adaptive radiotherapy using an expedited pre-plan workflow. Phys Imaging Radiat Oncol. 2024 Jul; 31:100611.. View in PubMed